Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer

NCT02229253 · clinicaltrials.gov ↗

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Hormone Sensitive Prostate Cancer

Interventions

DRUG: degarelix

Sponsor

Ferring Pharmaceuticals